Literature DB >> 7894871

A neural model of memory impairment in diffuse cerebral atrophy.

E Ruppin1, J A Reggia.   

Abstract

BACKGROUND: Computer-supported neural network models have been subjected to diffuse, progressive deletion of synapses/neurons, to show that modelling cerebral neuropathological changes can predict the pattern of memory degradation in diffuse degenerative processes such as Alzheimer's disease. However, it has been suggested that neural models cannot account for more detailed aspects of memory impairment, such as the relative sparing of remote versus recent memories.
METHOD: The latter claim is examined from a computational perspective, using a neural associative memory model.
RESULTS: The neural network model not only demonstrates progressive memory deterioration as diffuse network damage occurs, but also exhibits differential sparing of remote versus recent memories.
CONCLUSIONS: Our results show that neural models can account for a large variety of experimental phenomena characterising memory degradation in Alzheimer's patients. Specific testable predictions are generated concerning the relation between the neuraonatomical findings and the clinical manifestations of Alzheimer's disease.

Entities:  

Mesh:

Year:  1995        PMID: 7894871     DOI: 10.1192/bjp.166.1.19

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

1.  AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice.

Authors:  Eric H Chang; Mary J Savage; Dorothy G Flood; Justin M Thomas; Robert B Levy; Veeravan Mahadomrongkul; Tomoaki Shirao; Chiye Aoki; Patricio T Huerta
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

2.  Computational Psychiatry and Computational Neurology: Seeking for Mechanistic Modeling in Cognitive Impairment and Dementia.

Authors:  Ludmila Kucikova; Samuel Danso; Lina Jia; Li Su
Journal:  Front Comput Neurosci       Date:  2022-05-11       Impact factor: 3.387

3.  Beta-amyloid prevents excitotoxicity via recruitment of glial glutamate transporters.

Authors:  Atsushi Baba; Kazuhiko Mitsumori; Maki K Yamada; Nobuyoshi Nishiyama; Norio Matsuki; Yuji Ikegaya
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-04       Impact factor: 3.000

4.  Modeling Alzheimer's disease: from past to future.

Authors:  Claudia Saraceno; Stefano Musardo; Elena Marcello; Silvia Pelucchi; Monica Di Luca
Journal:  Front Pharmacol       Date:  2013-06-19       Impact factor: 5.810

5.  Information-selectivity of Beta-amyloid pathology in an associative memory model.

Authors:  Mark Rowan
Journal:  Front Comput Neurosci       Date:  2012-01-18       Impact factor: 2.380

6.  Learning to classify neural activity from a mouse model of Alzheimer's disease amyloidosis versus controls.

Authors:  Shlomit Beker; Vered Kellner; Gal Chechik; Edward A Stern
Journal:  Alzheimers Dement (Amst)       Date:  2016-02-03

Review 7.  Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).

Authors:  Mubashir Hassan; Qamar Abbas; Sung-Yum Seo; Saba Shahzadi; Hany Al Ashwal; Nazar Zaki; Zeeshan Iqbal; Ahmed A Moustafa
Journal:  Mol Med Rep       Date:  2018-05-22       Impact factor: 2.952

8.  Progressive effect of beta amyloid peptides accumulation on CA1 pyramidal neurons: a model study suggesting possible treatments.

Authors:  Viviana Culmone; Michele Migliore
Journal:  Front Comput Neurosci       Date:  2012-07-23       Impact factor: 2.380

9.  Computational modeling of the effects of amyloid-beta on release probability at hippocampal synapses.

Authors:  Armando Romani; Cristina Marchetti; Daniela Bianchi; Xavier Leinekugel; Panayiota Poirazi; Michele Migliore; Hélène Marie
Journal:  Front Comput Neurosci       Date:  2013-01-25       Impact factor: 2.380

10.  On the Complexity of Brain Disorders: A Symptom-Based Approach.

Authors:  Ahmed A Moustafa; Joseph Phillips; Szabolcs Kéri; Blazej Misiak; Dorota Frydecka
Journal:  Front Comput Neurosci       Date:  2016-02-23       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.